It has been previously reported that the administration of recombinant VEGF in an ischemic stroke model, and the overexpression of HIF1 in CMECs both increased angiogenesis but resulted in the disruption of tight junction proteins leading to BBB leakage and risk of hemorrhage [54, 55]. This evidence concerns the gene HIF1A and ischemic stroke.